Retatrutide Reconstitution: Vial Sizes, Water and Unit Conversions

Retatrutide is the newest name in the vial-math searches, and it needs the clearest disclaimer of any page in this series, so here it is up front: retatrutide is an investigational compound. It is still in clinical trials, it is not an approved medicine anywhere in the world, and there is no official dosing information for it outside those trials. What exists — and all this retatrutide calculator page provides — is the same reconstitution arithmetic as for any other lyophilised vial: how vial size and water volume combine into a concentration, and how a concentration turns an example amount into syringe units. If you are checking the maths on a research vial, here it is, worked in full.

The vial sizes in circulation, and their concentrations

Research-supply listings for retatrutide most commonly show 10 mg, 20 mg and 40 mg vials. Retatrutide reconstitution follows the universal recipe — add bacteriostatic water, swirl gently, refrigerate — and the universal formula: concentration = mg × 1,000 ÷ ml. The pairings I see chosen, and what they produce:

Units on a U-100 syringe. Two concentrations cover all four pairings — which is exactly why labelling the vial with its concentration matters more than labelling it with its size.

The fully worked row, as always: 20 mg is 20,000 mcg; in 2 ml that is 10,000 mcg in every ml. A 2 mg example amount is 2,000 mcg, needing 2,000 ÷ 10,000 = 0.20 ml — 20 units. A 1 mg example is 10 units; a 4 mg example is 40. At the 5,000 mcg/ml pairings, simply double each unit count. Notice how the 20 mg + 4 ml and 10 mg + 2 ml rows are identical in every column: same concentration, same draws, different vial — the cleanest illustration on this site of why units can never be copied between setups.

Working the “reta dosage calculator” questions by hand

The reta dosage calculator searches boil down to three questions, and each has a one-line method:

• “How many units is X mg?” Convert X to mcg (× 1,000), divide by your concentration, multiply by 100. Two mg at 5,000 mcg/ml: 2,000 ÷ 5,000 × 100 = 40 units.
• “How many draws per vial?” Divide the vial’s total mcg by the example amount. A 20 mg vial at 2 mg examples: 20,000 ÷ 2,000 = 10 draws, before real-world losses.
• “What concentration do I get if I add Y ml?” Vial mcg ÷ Y. A 40 mg vial with 4 ml: 40,000 ÷ 4 = 10,000 mcg/ml.

Or skip the pencil: the peptide calculator performs the same three operations for any numbers you enter, and the complete method lives in our complete reconstitution guide.

Handling notes for an investigational vial

Because there is no approved product and no official patient information leaflet, handling discipline matters more here, not less. The conservative, standard practice for lyophilised research peptides applies in full: reconstitute with bacteriostatic water added slowly down the vial wall; swirl, never shake; refrigerate the mixed vial (2–8 °C) protected from light; do not freeze a reconstituted solution unless the supplier explicitly supports it; write the compound, the date and the concentration on the label; and treat any vial that turns cloudy or shows particles as finished — discard it. Suppliers commonly advise using reconstituted research vials within a few weeks; there is no official figure for this compound, and I will not invent one.

Provenance deserves one plain sentence too: a research chemical’s label is a claim by its seller, not a regulator’s verification, and neither this page nor any calculator can verify what is actually in a vial. That uncertainty is part of why the only responsible answers about amounts, suitability and safety sit with medical professionals and the published trial literature — not with arithmetic.

Multi-entry hygiene: the unglamorous section that matters most

A reconstituted vial is entered again and again over its life, and every entry is a small contamination opportunity that sterile technique exists to close down. The routine is short enough to have no excuse: swab the stopper before every entry, not just the first; let the alcohol dry rather than pushing a wet needle through it; use a fresh sterile needle and syringe for each draw; and never return drawn solution to the vial. None of this appears in any dosage table, and all of it decides whether the last draw from the vial is as safe as the first. For a compound with no regulator inspecting its manufacture, the discipline of the person holding the syringe is the only quality system in the room — behave like it.

How retatrutide’s maths compares with its better-known cousins

If you have worked through the tirzepatide and semaglutide tables, retatrutide holds no surprises: its vial sizes (10–40 mg) sit in the same range as tirzepatide’s, its convenient concentrations are the same 5,000 and 10,000 mcg/ml, and the errors to avoid are the same — the mg-to-mcg factor of 1,000, and unit counts smuggled in from a different concentration. The compounds differ in the laboratory; at the calculator, they are identical. The worked tables for those two are in the tirzepatide and semaglutide vial math guide, if you want the side-by-side.

A complete worked vial, start to finish

Let me run one vial through the entire pipeline the way I would at the bench. The vial: 40 mg of retatrutide. I choose 4 ml of bacteriostatic water — on the logic this series repeats: it lands the concentration on the round 10,000 mcg/ml (40,000 mcg ÷ 4 ml), and round concentrations make every later conversion checkable at a glance. Water in slowly down the wall, rest, swirl until clear, label: “Retatrutide — 10,000 mcg/ml — [date]”. From that label, every example amount is a single division: 1 mg (1,000 mcg) is 10 units; 2 mg is 20 units; 4 mg is 40 units; 6 mg is 60 units; 8 mg is 80 units. Draws per vial at 2 mg examples: 40,000 ÷ 2,000 = 20 on paper, fewer in life after priming and dead-space losses. Total working time, including the labelling people skip: under five minutes, of which the arithmetic was perhaps thirty seconds. The rest is hygiene — which, for a compound with no regulator looking over the manufacturer’s shoulder, is not a garnish on the process; it is the process.

What “investigational” means for the vial in your hand

It is worth spelling out what the word investigational removes. An approved medicine’s vial comes with a regulator-verified identity, a tested purity, a leaflet with regulator-approved information and a manufacturer answerable for all three. A research vial of retatrutide has none of that scaffolding: the label is the seller’s assertion, “third-party tested” is the seller’s chosen laboratory, and the compound’s behaviour in humans exists, so far, only inside the published trial record — which studies carefully screened participants under medical supervision, a context no home reconstitution reproduces. I raise this not to lecture but because it changes the maths’ meaning: the calculations on this page can tell you exactly how much liquid is in a syringe; they cannot tell you what is dissolved in it, and for an investigational compound that gap is larger than usual. Anyone weighing that gap deserves to weigh it with a medical professional, not a calculator — the calculator’s job ends, deliberately, at the units.

Reading a certificate of analysis without being fooled by one

Serious research suppliers attach a certificate of analysis (COA) to a batch, and retatrutide buyers lean on these documents heavily — so it is worth knowing what one can and cannot establish. A genuine COA reports two different things: identity, usually from mass spectrometry, confirming the molecule’s mass matches retatrutide’s; and purity, usually from HPLC, reporting what percentage of the sample is that molecule (98–99% is the figure commonly claimed). What a COA cannot tell you: that the vial in your hand came from the batch tested, that the stated milligrams are net peptide rather than powder weight, or that the laboratory named is independent of the seller. Batch numbers that match between vial and certificate, a laboratory you can find independently, and consistency across suppliers’ documents are the meaningful signals; a beautiful PDF is not. None of this changes a single number in this article’s tables — concentration maths runs on the label’s claims — but it should change how much weight those claims are asked to bear.

The 20 mg vial, three ways: choosing a concentration on purpose

Finally, the decision this page keeps circling, made concrete. A 20 mg retatrutide vial accepts a range of sensible concentrations: 2 ml of water gives 10,000 mcg/ml (1 mg = 10 units; 2 mg = 20; 4 mg = 40); 4 ml gives 5,000 mcg/ml (doubling every draw: 20, 40, 80 units); and 3 ml gives 6,667 mcg/ml, a concentration I include only to argue against — its repeating decimals (1 mg = 15 units is clean, but 2 mg = 30 and 4 mg = 60 hide the fact that 500 mcg lands on 7.5 units) buy nothing a round concentration does not do better. Choose the water that makes your most frequent example amounts land on whole, readable marks, prefer round concentrations, and write the winner on the label. That is the entire philosophy of this series in one vial.

Sources: reconstitution arithmetic (concentration = mg × 1,000 ÷ ml; U-100 syringe, 100 units = 1 ml) applied to the retatrutide vial sizes commonly listed by research suppliers (10, 20 and 40 mg); the compound’s investigational status reflects its position in published clinical-trial registries at the time of writing (October 2026). Every figure recomputed for this article. Educational arithmetic only — not medical advice.